Direct health care costs of children and adolescents with Down syndrome.

摘要: Objective To assess the direct annual health care costs for children and adolescents with Down syndrome in Western Australia to explore variation use including respite, according age disease profile. Study design Population-based data were derived from a cross-sectional questionnaire that was distributed all families who had child as old 25 years of Australia. Results Seventy-three percent (363/500) responded survey. Mean cost $4209 Australian dollars ($4287 US dollars) hospital, medical, pharmaceutical, respite therapy, median $1701. Overall, decreased age. The decline result decreasing therapy Conversely, increased also dependency. Health greater groups increasing dependency an earlier or current diagnosis congenital heart disease. Annual did not vary parental income, respite. Conclusions Direct decrease approximate population costs, although show trend.